Helicobacter Pylori antibiotic sensitivity pattern in dyspeptic patients in Kano, Nigeria

Southern African Journal of Infectious Diseases

 
 
Field Value
 
Title Helicobacter Pylori antibiotic sensitivity pattern in dyspeptic patients in Kano, Nigeria
 
Creator Bello, Ahmad K. Borodo, Mohammad M. Yakasai, Ahmad M. Tukur, Abubakar D.
 
Subject — H. pylori Antibiotic Sensitivity; Kano – Nigeria; H. pylori Culture; Histology; Clarithromycin and Levofloxacin Sensitivity.
Description Background: Despite the high prevalence of Helicobacter pylori infection in Nigeria, in the North-West there are no studies on the antibiotic sensitivity pattern of this organism. This study aims to determine the antibiotic sensitivity pattern of this bacterium as well as bridge the gap in knowledge.Methods: The study was cross-sectional in design. Questionnaires were administered in dyspeptic patients to obtain the relevant data. Two sets of gastric biopsy specimens were taken during upper gastrointestinal (GI) endoscopy. One set was sent to the histopathology laboratory for assessment and H. pylori identification, while the other set for culture was minced and plated on Columbia blood agar media (Oxoid Ltd, England) incubated at 37°C in an anaerobic jar containing CampyGen (Oxoid Ltd) to provide the required micro-aerobic environment. The disc diffusion method was used in determining the sensitivity pattern of isolates. Pre-treatment and post-treatment stool samples were collected from each patient for a H. pylori faecal antigen test to assess eradication rate.Results: The sensitivity of H. pylori to amoxicillin was 9.2%, and 100% for both clarithromycin and levofloxacin. Tetracycline, metronidazole, cefuroxime, tinidazole and ciprofloxacin were 100% resitant. The prevalence of H. pylori at histology was 81.7%. Only 101 subjects had a positive H. pylori stool antigen test.Conclusion: This study showed a high amoxicillin resistance; however, there is high sensitivity (100%) to clarithromycin and levofloxacin. We recommended that levofloxacin be adopted in preference to amoxicillin as part of triple therapy in Nigeria.
 
Publisher AOSIS Publishing
 
Contributor
Date 2019-10-17
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — —
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/sajid.v34i1.125
 
Source Southern African Journal of Infectious Diseases; Vol 34, No 1 (2019); 7 pages 2313-1810 2312-0053
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajid.co.za/index.php/sajid/article/view/125/166 https://sajid.co.za/index.php/sajid/article/view/125/165 https://sajid.co.za/index.php/sajid/article/view/125/167 https://sajid.co.za/index.php/sajid/article/view/125/164
 
Coverage — — —
Rights Copyright (c) 2019 Ahmad K. Bello, Mohammad M. Borodo, Ahmad M. Yakasai, Abubakar D. Tukur https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT